Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Drug Testing and Analysis, 7(1), 31-38
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Adverse reactions reported in these studies listed by system organ class included: ventricular extrasystoles Cardiac disorders: electrocardiogram repolarization abnormality, heart rate increased Investigations: pleural effusion Respiratory, thoracic, and mediastinal disorders: Adverse reactions common to both the studies in known or suspected cyanide poisoning victims and the study in healthy volunteers are listed in the healthy volunteer section only and are not duplicated in this list
Womens Health Mens Health Obstetric shared care Antenatal and Postnatal Chronic disease management Mental Health Childhood and workplace immunizations On-site Clinpath Lab Allied healthcare services Open for Appointments HOW TO PAY South Road Day/Night Surgery Additional fees may apply for surgical procedures
As B12 levels are replenished through injections, many patients experience a significant increase in energy, reduced fatigue, and improved overall vitality
So when people talk about GHK-Cu before and after results, theyre really talking about a restoration peptide, not a quick-fix cream
